Cough Be Gone
NDC Package 76206-001-01
Package Information
Cough Be Gone is ■ do not take more than 6 doses in any 24-hour period■ one dose is one bottle■ this adult product is not intended for use in children under 12 years of ageAge DoseAdults and Children one bottle (10 ml)12 years and over every 4 hoursChildren under 12 years do not use. Marketed by Rfx Pharmaceutical Co., Ltd., this product is identified by NDC 76206-001 and is authorized under FDA application part341.
Identification & Billing
- RxCUI: 996520 - dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 10 mL Oral Solution
- RxCUI: 996520 - dextromethorphan hydrobromide 2 MG/ML / guaifenesin 20 MG/ML Oral Solution
- RxCUI: 996520 - dextromethorphan hydrobromide 10 MG / guaifenesin 100 MG per 5 ML Oral Solution
- RxCUI: 996520 - dextromethorphan hydrobromide 15 MG / guaifenesin 150 MG per 7.5 ML Oral Solution
- RxCUI: 996520 - dextromethorphan hydrobromide 20 MG / guaifenesin 200 MG per 10 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 76206 - Rfx Pharmaceutical Co., Ltd.
- 76206-001 - Cough Be Gone
- 76206-001-01 - 6 BOTTLE, GLASS in 1 BOX / 10 mL in 1 BOTTLE, GLASS (76206-001-10)
- 76206-001 - Cough Be Gone
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 76206-001-01 identifies a specific commercial package of 6 bottle, glass in 1 box / 10 ml in 1 bottle, glass (76206-001-10) of Cough Be Gone, labeled by Rfx Pharmaceutical Co., Ltd.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rfx Pharmaceutical Co., Ltd. on January 30, 2014. The current certification is valid through December 31, 2021.
How is this Rfx Pharmaceutical Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 76206000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.